Across TCGA pan-cancer cohorts, RNU6-1103P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-1103P data layer.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6-1103P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1103P expression acts as an unfavorable survival marker.
HNSC are the cancer types where RNU6-1103P RNA most reproducibly stratifies survival.